Cell Biosciences

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

Paired Ends

Premium

Sam Mohan

The protein analysis firm also said that it raised $13 million in connection with the deal.

New Products

Premium

Cell Biosciences

Paired Ends

Premium

Mark Dronsfield, Bernd Brust, Jeremy Berg, Mark Poznansky

A number of prominent proteomics-based diagnostics developers were recipients of the grant and tax credit awards, which are being provided by the IRS through the Patient Protection and Affordable Care Act's Qualifying Therapeutic Discovery Project Program.

Paired Ends

Premium

Lloyd Kunimoto, Martin Burow, Richard Lussier, Ingrid Choupin

With the assay, the Stanford researchers have begun examining protein phosphorylation levels in a variety of cancer types. The team has also entered into collaborations with several pharmaceutical firms to investigate the effects of therapeutic agents on protein phosphorylation levels in tumor cells.

The deal is expected to expand Cell Biosciences' protein analysis product portfolio "and transform Cell Biosciences into the premier provider of capillary-based protein analysis technology," the company said.

New Products

Premium

Cell Biosciences, Proteome Software, TTP LabTech

Pages

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.

The New York Times reports that evidence linking trauma in one generation to epigenetic effects that influence subsequent generations may be overstated.

ScienceInsider reports that US National Institutes of Health researchers were told in the fall they could not obtain new human fetal tissue.

In PNAS this week: skin pigmentation evolution among KhoeSan, biomarkers for dengue virus progression, and more.